Search

Author/Creator Gordon, K.B.

1. A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial. (15th January 2020)

Authors:
Blauvelt, A.; Papp, K.; Gottlieb, A.; Jarell, A.; Reich, K.; Maari, C.; Gordon, K.B.; Ferris, L.K.; Langley, R.G.; Tada, Y.; Lima, R.G.; Elmaraghy, H.; Gallo, G.; Renda, L.; Park, S.Y.; Burge, R.; Bagel, J.
Other Names:
Vender Ronald investigator.; Lomaga Mark A. investigator.; Delorme Isabelle investigator.; Hong Chih‐Ho investigator.; Langley Richard L. investigator.; Albrecht Lorne investigator.; Guenther Lyn investigator.; Maari Catherine investigator.; Papp Kim investigator.; Singh Ohson Kamal K. investigat...
Journal:
British journal of dermatology
Issue:
Volume 182:Number 6(2020)
Page Start:
1348
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial. (1st June 2020)

Authors:
Blauvelt, A.; Papp, K.; Gottlieb, A.; Jarell, A.; Reich, K.; Maari, C.; Gordon, K.B.; Ferris, L.K.; Langley, R.G.; Tada, Y.; Lima, R.G.; Elmaraghy, H.; Gallo, G.; Renda, L.; Park, S.Y.; Burge, R.; Bagel, J.; Vender, Ronald; Lomaga, Mark A.; Delorme, Isabelle
Journal:
British journal of dermatology
Issue:
Volume 182:Number 6(2020)
Page Start:
1348
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A high level of clinical response is associated with improved patient‐reported outcomes in psoriasis: analyses from a phase 2 study in patients treated with ixekizumab. (13th March 2015)

Authors:
Edson‐Heredia, E.; Banerjee, S.; Zhu, B.; Maeda‐Chubachi, T.; Cameron, G.S.; Shen, W.; Heffernan, M.P.; Gordon, K.B.; Leonardi, C.L.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 30:Number 5(2016:May)
Page Start:
864
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A study comparing the biologic drugs ixekizumab and guselkumab for the treatment of moderate‐to‐severe plaque psoriasis. (1st June 2020)

Authors:
Blauvelt, A.; Papp, K.; Gottlieb, A.; Jarell, A.; Reich, K.; Maari, C.; Gordon, K.B.; Ferris, L.K.; Langley, R.G.; Tada, Y.; Lima, R.G.; Elmaraghy, H.; Gallo, G.; Renda, L.; Park, S.Y.; Burge, R.; Bagel, J.
Journal:
British journal of dermatology
Issue:
Volume 182:Number 6(2020)
Page Start:
e193
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Adalimumab retreatment successfully restores clinical response and health‐related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption. (3rd October 2014)

Authors:
Gordon, K.B.; Gottlieb, A.B.; Langely, R.G.; van de Kerkhof, P.; Belasco, K.T.; Sundaram, M.; Okun, M.; Serra, L.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 29:Number 4(2015:Apr.)
Page Start:
767
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Anxiety and depression in patients with moderate‐to‐severe psoriasis and comparison of change from baseline after treatment with guselkumab vs. adalimumab: results from the Phase 3 VOYAGE 2 study. (18th July 2018)

Authors:
Gordon, K.B.; Armstrong, A.W.; Han, C.; Foley, P.; Song, M.; Wasfi, Y.; You, Y.; Shen, Y.‐K.; Reich, K.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 32:Number 11(2018)
Page Start:
1940
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis. (31st March 2017)

Authors:
Blauvelt, A.; Papp, K.A.; Sofen, H.; Augustin, M.; Yosipovitch, G.; Katoh, N.; Mrowietz, U.; Ohtsuki, M.; Poulin, Y.; Shrom, D.; Burge, R.; See, K.; Mallbris, L.; Gordon, K.B.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 31:Number 6(2017)
Page Start:
1004
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Correlation of psoriasis activity with socioeconomic status: cross‐sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR). (1st October 2018)

Authors:
Kimball, A.B.; Augustin, M.; Gordon, K.B.; Krueger, G.G.; Pariser, D.; Fakharzadeh, S.; Goyal, K.; Calabro, S.; Lee, S.; Lin, R.; Li, N.; Srivastava, B.; Guenther, L.
Journal:
British journal of dermatology
Issue:
Volume 179:Number 4(2018)
Page Start:
984
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗